A citation-based method for searching scientific literature

A C Keech, P Mitchell, P A Summanen, J O'Day, T M E Davis, M S Moffitt, M-R Taskinen, R J Simes, D Tse, E Williamson, A Merrifield, L T Laatikainen, M C d'Emden, D C Crimet, R L O'Connell, P G Colman. Lancet 2007
Times Cited: 623







List of co-cited articles
1497 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of medical therapies on retinopathy progression in type 2 diabetes.
Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue,[...]. N Engl J Med 2010
731
63

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
25

Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Ying Chen, Yang Hu, Mingkai Lin, Alicia J Jenkins, Anthony C Keech, Robert Mott, Timothy J Lyons, Jian-xing Ma. Diabetes 2013
106
21

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou,[...]. Lancet 2005
19


The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
Emily Y Chew, Matthew D Davis, Ronald P Danis, James F Lovato, Letitia H Perdue, Craig Greven, Saul Genuth, David C Goff, Lawrence A Leiter, Faramarz Ismail-Beigi,[...]. Ophthalmology 2014
138
13

Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.
Yang Hu, Ying Chen, Lexi Ding, Xuemin He, Yusuke Takahashi, Yang Gao, Wei Shen, Rui Cheng, Qian Chen, Xiaoping Qi,[...]. Proc Natl Acad Sci U S A 2013
80
16


Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
11

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
10

Neuroprotective effects of PPARα in retinopathy of type 1 diabetes.
Elizabeth A Pearsall, Rui Cheng, Satoshi Matsuzaki, Kelu Zhou, Lexi Ding, Bumsoo Ahn, Michael Kinter, Kenneth M Humphries, Alexander B Quiambao, Rafal A Farjo,[...]. PLoS One 2019
20
50

Effects of combination lipid therapy in type 2 diabetes mellitus.
Henry N Ginsberg, Marshall B Elam, Laura C Lovato, John R Crouse, Lawrence A Leiter, Peter Linz, William T Friedewald, John B Buse, Hertzel C Gerstein, Jeffrey Probstfield,[...]. N Engl J Med 2010
9

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
Aruna D Pradhan, Nina P Paynter, Brendan M Everett, Robert J Glynn, Pierre Amarenco, Marshall Elam, Henry Ginsberg, William R Hiatt, Shun Ishibashi, Wolfgang Koenig,[...]. Am Heart J 2018
137
9

Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.
E Y Chew, M L Klein, F L Ferris, N A Remaley, R P Murphy, K Chantry, B J Hoogwerf, D Miller. Arch Ophthalmol 1996
414
9

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
485
9


Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Lexi Ding, Rui Cheng, Yang Hu, Yusuke Takahashi, Alicia J Jenkins, Anthony C Keech, Kenneth M Humphries, Xiaowu Gu, Michael H Elliott, Xiaobo Xia,[...]. Am J Pathol 2014
49
16

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
David R Matthews, Irene M Stratton, Stephen J Aldington, Rury R Holman, Eva M Kohner. Arch Ophthalmol 2004
258
8

Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model.
Yohei Tomita, Nobuhiro Ozawa, Yukihiro Miwa, Ayako Ishida, Masayuki Ohta, Kazuo Tsubota, Toshihide Kurihara. Int J Mol Sci 2019
15
53

PPARα is essential for retinal lipid metabolism and neuronal survival.
Elizabeth A Pearsall, Rui Cheng, Kelu Zhou, Yusuke Takahashi, H Greg Matlock, Shraddha S Vadvalkar, Younghwa Shin, Thomas W Fredrick, Marin L Gantner, Steven Meng,[...]. BMC Biol 2017
23
34

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
Nish Chaturvedi, Massimo Porta, Ronald Klein, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Anne Katrin Sjølie. Lancet 2008
293
8

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
Kushwin Rajamani, Peter G Colman, Li Ping Li, James D Best, Merryn Voysey, Michael C D'Emden, Markku Laakso, John R Baker, Anthony C Keech. Lancet 2009
164
7

Inflammation in diabetic retinopathy.
Johnny Tang, Timothy S Kern. Prog Retin Eye Res 2011
623
7


Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
J W J Beulens, A Patel, J R Vingerling, J K Cruickshank, A D Hughes, A Stanton, J Lu, S A McG Thom, D E Grobbee, R P Stolk. Diabetologia 2009
110
7

PPARalpha: an emerging therapeutic target in diabetic microvascular damage.
Anne Hiukka, Marianna Maranghi, Niina Matikainen, Marja-Riitta Taskinen. Nat Rev Endocrinol 2010
80
8

Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Michael Mauer, Bernard Zinman, Robert Gardiner, Samy Suissa, Alan Sinaiko, Trudy Strand, Keith Drummond, Sandra Donnelly, Paul Goodyer, Marie Claire Gubler,[...]. N Engl J Med 2009
493
7

An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.
Jonathan E Noonan, Alicia J Jenkins, Jian-Xing Ma, Anthony C Keech, Jie Jin Wang, Ecosse L Lamoureux. Diabetes 2013
69
10

Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.
Jean-Sébastien Joyal, Ye Sun, Marin L Gantner, Zhuo Shao, Lucy P Evans, Nicholas Saba, Thomas Fredrick, Samuel Burnim, Jin Sung Kim, Gauri Patel,[...]. Nat Med 2016
111
7

Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.
Eugene Yu-Chuan Kang, Tien-Hsing Chen, Sunir J Garg, Chi-Chin Sun, Je-Ho Kang, Wei-Chi Wu, Ming-Jui Hung, Chi-Chun Lai, Wen-Jin Cherng, Yih-Shiou Hwang. JAMA Ophthalmol 2019
32
21

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
7

Protective and antioxidant effects of PPARα in the ischemic retina.
Elizabeth Moran, Lexi Ding, Zhongxiao Wang, Rui Cheng, Qian Chen, Robert Moore, Yusuke Takahashi, Jian-xing Ma. Invest Ophthalmol Vis Sci 2014
42
16

Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
908
7

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
6

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
6

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.
Marc S Sabatine, Lawrence A Leiter, Stephen D Wiviott, Robert P Giugliano, Prakash Deedwania, Gaetano M De Ferrari, Sabina A Murphy, Julia F Kuder, Ioanna Gouni-Berthold, Basil S Lewis,[...]. Lancet Diabetes Endocrinol 2017
274
6

A central role for inflammation in the pathogenesis of diabetic retinopathy.
Antonia M Joussen, Vassiliki Poulaki, Minh Ly Le, Kan Koizumi, Christina Esser, Hanna Janicki, Ulrich Schraermeyer, Norbert Kociok, Sascha Fauser, Bernd Kirchhof,[...]. FASEB J 2004
791
6

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.
Elia J Duh, Jennifer K Sun, Alan W Stitt. JCI Insight 2017
257
6

Mechanism of action of fibrates on lipid and lipoprotein metabolism.
B Staels, J Dallongeville, J Auwerx, K Schoonjans, E Leitersdorf, J C Fruchart. Circulation 1998
6

Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes.
Patricia Bogdanov, Cristina Hernández, Lidia Corraliza, Andrea R Carvalho, Rafael Simó. Acta Diabetol 2015
27
22

The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.
Patricia Bogdanov, Lidia Corraliza, Josep A Villena, Andrea R Carvalho, José Garcia-Arumí, David Ramos, Jesús Ruberte, Rafael Simó, Cristina Hernández. PLoS One 2014
98
6

Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Bin Wang, Fang Wang, Yue Zhang, Shi-Hua Zhao, Wen-Juan Zhao, Sheng-Li Yan, Yan-Gang Wang. Lancet Diabetes Endocrinol 2015
61
9

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
890
6

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.
A J Barber, E Lieth, S A Khin, D A Antonetti, A G Buchanan, T W Gardner. J Clin Invest 1998
900
6

Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Yan Gong, Zhuo Shao, Zhongjie Fu, Matthew L Edin, Ye Sun, Raffael G Liegl, Zhongxiao Wang, Chi-Hsiu Liu, Samuel B Burnim, Steven S Meng,[...]. EBioMedicine 2016
27
22

Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
Rui Cheng, Lexi Ding, Xuemin He, Yusuke Takahashi, Jian-Xing Ma. Diabetes 2016
37
16

Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial.
Hertzel C Gerstein, Walter T Ambrosius, Ronald Danis, Faramarz Ismail-Beigi, William Cushman, Jorge Calles, Maryann Banerji, Ulrich Schubart, Emily Y Chew. Diabetes Care 2013
67
8


The progress in understanding and treatment of diabetic retinopathy.
Alan W Stitt, Timothy M Curtis, Mei Chen, Reinhold J Medina, Gareth J McKay, Alicia Jenkins, Thomas A Gardiner, Timothy J Lyons, Hans-Peter Hammes, Rafael Simó,[...]. Prog Retin Eye Res 2016
329
6

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
I M Stratton, E M Kohner, S J Aldington, R C Turner, R R Holman, S E Manley, D R Matthews. Diabetologia 2001
572
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.